• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.78% Nasdaq Down 1.13%

    More On IPH.PA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Innate Pharma S.A. (IPH.PA)

    -Paris
    12.16 Down 0.34(2.72%) May 3
    Prev Close:12.16
    Open:12.50
    Bid:12.15 x 29000
    Ask:12.26 x 25000
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:12.11 - 12.52
    52wk Range:9.21 - 16.59
    Volume:239,202
    Avg Vol (3m):281,404
    Market Cap:654.30M
    P/E (ttm):N/A
    EPS (ttm):-0.13
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in EUR.

    Headlines

    » More Headlines for IPH.PA

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.94
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Innate Pharma S.A., a biopharmaceutical company, engages in the research and development of pharmaceutical product primarily immunotherapy drugs for cancer and inflammatory diseases in France. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback